GlobeNewswire: nContact, Inc. Contains the last 10 of 23 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T12:49:47ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2015/07/21/753803/0/en/nContact-Appoints-William-Hawkins-Former-CEO-of-Medtronic-Inc-as-Board-Chairman.html?f=22&fvtc=4&fvtv=19198nContact Appoints William Hawkins, Former CEO of Medtronic, Inc., as Board Chairman2015-07-21T13:00:00Z<![CDATA[MORRISVILLE, N.C., July 21, 2015 (GLOBE NEWSWIRE) -- nContact, a leader in the development of Arrhythmia and Cardiovascular Disease Management Programs, announced that William (Bill) Hawkins has been appointed as Chairman of its Board of Directors.]]>https://www.globenewswire.com/news-release/2015/05/07/733633/0/en/nContact-Supporting-Continuing-Medical-Education-Symposium-on-Persistent-Atrial-Fibrillation-Treatments-at-Heart-Rhythm-Society-2015.html?f=22&fvtc=4&fvtv=19198nContact Supporting Continuing Medical Education Symposium on Persistent Atrial Fibrillation Treatments at Heart Rhythm Society 20152015-05-07T15:47:06Z<![CDATA[MORRISVILLE, N.C., May 7, 2015 (GLOBE NEWSWIRE) -- nContact, a leader in the development of Arrhythmia & Cardiovascular Disease Management Programs, announced educational support for a CME Symposium at the upcoming Heart Rhythm Society (HRS) 2015 meeting in Boston, MA, next week. The program is titled “Can You Successfully Treat Persistent Atrial Fibrillation without Silencing the Posterior Left Atrium? Setting a Standard for Single-Procedure Outcomes” and is being held during lunch on Wednesday May 13, at the Westin Boston Waterfront, Grand Ballroom B.]]>https://www.globenewswire.com/news-release/2014/12/09/689746/10111486/en/nContact-Presents-at-the-Piper-Jaffray-26th-Annual-Healthcare-Conference.html?f=22&fvtc=4&fvtv=19198nContact Presents at the Piper Jaffray 26th Annual Healthcare Conference2014-12-09T13:00:00Z<![CDATA[CEO Highlights Need to Address Large, Unmet Markets and Set a New Standard for Ablation Success MORRISVILLE, N.C., Dec. 9, 2014 (GLOBE NEWSWIRE) -- nContact, a leader in the development of Arrhythmia Disease Management Programs, announced that CEO John Funkhouser was invited to speak at the Piper Jaffray 26]]>https://www.globenewswire.com/news-release/2014/11/12/682550/10107874/en/nContact-Secures-20-Million-in-Growth-Capital-Financing.html?f=22&fvtc=4&fvtv=19198nContact Secures $20 Million in Growth Capital Financing2014-11-12T15:54:29Z<![CDATA[Funding Will Expand Ongoing Clinical Trials to Treat Persistent Atrial Fibrillation and Accelerate Growth of Global Disease Management Programs MORRISVILLE, N.C., Nov. 12, 2014 (GLOBE NEWSWIRE) -- nContact, a leader in the development of Arrhythmia Disease Management Programs, announced that it has entered into a $20 million growth capital financing agreement with Hercules Technology Growth Capital, Inc., (NYSE:HTGC) , the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets, including, life science. The company plans to use this financing to support its ongoing CONVERGE IDE Clinical Trial, expand its field support teams, and further next-generation product development.]]>https://www.globenewswire.com/news-release/2014/10/28/677240/10104832/en/Our-Lady-of-the-Lake-Regional-Medical-Center-Presents-the-Largest-Clinical-Experience-on-the-Convergent-Procedure-224-Patients-Treated-for-Atrial-Fibrillation.html?f=22&fvtc=4&fvtv=19198Our Lady of the Lake Regional Medical Center Presents the Largest Clinical Experience on the Convergent Procedure -- 224 Patients Treated for Atrial Fibrillation2014-10-28T14:29:12Z<![CDATA[Standardized, First-Line Approach Demonstrates 93% of Patients in Sinus Rhythm at 1-Year Follow-Up MORRISVILLE, N.C., Oct. 28, 2014 (GLOBE NEWSWIRE) -- New physician experience for the Convergent Procedure in the treatment of persistent atrial fibrillation (AF) was presented during a podium talk at the Northeast Cardiothoracic Surgical Society 20]]>https://www.globenewswire.com/news-release/2014/10/21/674982/10103615/en/The-Convergent-Procedure-Continues-to-Meet-the-Challenges-of-Treating-Persistent-Atrial-Fibrillation-Multiple-European-Centers-Report-Consistent-Long-Term-Results.html?f=22&fvtc=4&fvtv=19198The Convergent Procedure Continues to Meet the Challenges of Treating Persistent Atrial Fibrillation -- Multiple European Centers Report Consistent Long-Term Results2014-10-21T15:16:47Z<![CDATA[Four Studies Including 161 Patients Show Importance of Procedure Standardization MORRISVILLE, N.C., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Four European centers performing the Convergent Procedure recently presented data that continues to highlight consistent long-term results in the treatment of persistent atrial fibrillation (AF). AF is the most common arrhythmia, estimated to affect 15 million people in the Western world, with an estimated 88% falling into the difficult-to-treat persistent AF population. All patients in the 4 studies had persistent AF, and one third to nearly one half of patients had failed previous endocardial catheter ablations.]]>https://www.globenewswire.com/news-release/2014/09/25/668470/10099985/en/Convergent-Procedure-Using-Cryoballoon-Demonstrates-Promise-of-New-Ablation-Approach-in-the-Treatment-of-Persistent-Atrial-Fibrillation.html?f=22&fvtc=4&fvtv=19198Convergent Procedure Using Cryoballoon Demonstrates Promise of New Ablation Approach in the Treatment of Persistent Atrial Fibrillation2014-09-25T13:00:00Z<![CDATA[Dr. Suneet Mittal From The Valley Health System Presented Initial Experience at the European Society of Cardiology Meeting MORRISVILLE, N.C., Sept. 25, 2014 (GLOBE NEWSWIRE) -- A new ablation approach for the treatment of persistent and longstanding persistent atrial fibrillation (AF) patients was presented earlier this month during the poster sessions at the European Society of Cardiology Congress in Barcelona, Spain. This hybrid approach utilizes a cryoballoon as part of the multidisciplinary Convergent procedure in the treatment of persistent AF patients. AF is estimated to affect 5.9 million people in the U.S., with a majority of patients falling into the difficult-to-treat persistent AF population.]]>https://www.globenewswire.com/news-release/2014/03/12/617749/10072341/en/New-Publication-From-The-Valley-Health-System-Highlights-the-Convergent-Procedure-as-a-Go-To-Approach-for-Persistent-Atrial-Fibrillation-Patients.html?f=22&fvtc=4&fvtv=19198New Publication From The Valley Health System Highlights the Convergent Procedure as a "Go-To" Approach for Persistent Atrial Fibrillation Patients2014-03-12T13:35:11Z<![CDATA[Dr. Jason Sperling and Dr. Jonathan Steinberg Discuss New Treatment Opportunities Utilizing the Convergent Procedure MORRISVILLE, N.C., March 12, 2014 (GLOBE NEWSWIRE) -- ]]>https://www.globenewswire.com/news-release/2014/03/03/615077/10070872/en/New-Concept-on-Progression-of-Atrial-Fibrillation-Points-to-Importance-of-Comprehensive-Posterior-Left-Atrial-Ablation-Highlights-Role-of-Convergent-Procedure-in-the-Treatment-of-A.html?f=22&fvtc=4&fvtv=19198New Concept on Progression of Atrial Fibrillation Points to Importance of Comprehensive Posterior Left Atrial Ablation -- Highlights Role of Convergent Procedure in the Treatment of Atrial Fibrillation2014-03-03T15:38:52Z<![CDATA[Presentation From The Valley Health System of New York and New Jersey Outlined Mechanical Stress as a Potential Precursor to Atrial Fibrillation at the Seventh Annual Western Atrial Fibrillation Symposium MORRISVILLE, N.C., March 3, 2014 (GLOBE NEWSWIRE) -- A new concept on the progression of atrial fibrillation (AF) and the importance for providing comprehensive posterior left atrial ablation was presented during the Seventh Annual Western Atrial Fibrillation Conference held last week in Park City, Utah. AF is the most common cardiac arrhythmia, estimated to affect 5.9 million people in the U.S., with many patients falling into the difficult-to-treat persistent AF population.]]>https://www.globenewswire.com/news-release/2014/01/09/601407/10063558/en/Three-Year-Outcomes-for-the-Multidisciplinary-Convergent-Procedure-in-the-Treatment-of-Persistent-Atrial-Fibrillation-New-Data-Presented-at-Atrial-Fibrillation-Symposium.html?f=22&fvtc=4&fvtv=19198Three-Year Outcomes for the Multidisciplinary Convergent Procedure in the Treatment of Persistent Atrial Fibrillation - New Data Presented at Atrial Fibrillation Symposium2014-01-09T14:00:00Z<![CDATA[University Medical Center Ljubljana Reports Longest Convergent Procedure Follow-Up to Date at the Atrial Fibrillation Symposium 19th Annual Meeting MORRISVILLE, N.C., Jan. 9, 2014 (GLOBE NEWSWIRE) -- A new physician poster presentation at the Atrial Fibrillation Symposium 19]]>